ICD-10 Coding for Parathyroid Adenoma(D35.1, E21.0)
Complete ICD-10-CM coding and documentation guide for Parathyroid Adenoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Parathyroid Adenoma
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D35.1 | Benign neoplasm of parathyroid gland | Use when a benign parathyroid neoplasm is confirmed without hyperparathyroidism. |
|
| E21.0 | Primary hyperparathyroidism | Use when primary hyperparathyroidism is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for parathyroid adenoma
Essential facts and insights about Parathyroid Adenoma
Primary ICD-10-CM Codes for parathyroid adenoma
Decision Criteria
clinical Criteria
- Histopathological confirmation of benign neoplasm
Applicable To
- Parathyroid adenoma
Excludes
- Malignant neoplasm of parathyroid gland (C75.0)
Clinical Validation Requirements
- Histopathological confirmation of benign parathyroid neoplasm
Code-Specific Risks
- Misclassification if malignancy is present
Coding Notes
- Ensure histopathological confirmation to avoid misclassification.
E21.0 - Primary hyperparathyroidism
Use when primary hyperparathyroidism is confirmed.
Applicable To
- Hyperparathyroidism due to parathyroid adenoma
Excludes
- Secondary hyperparathyroidism (E21.1)
Clinical Validation Requirements
- Elevated serum calcium and PTH levels
Coding Notes
Ensure primary hyperparathyroidism is not secondary to another condition.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Parathyroid Adenoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D35.1.
Impact
Clinical: Inadequate clinical information for follow-up care., Regulatory: Potential non-compliance with documentation standards., Financial: Risk of denied claims due to insufficient documentation.
Mitigation Strategy
Use detailed templates for surgical documentation, Ensure all relevant clinical data is recorded
Impact
Reimbursement: May lead to incorrect billing and reimbursement., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data representation.
Mitigation Strategy
Ensure specific diagnosis of primary or secondary hyperparathyroidism.
Impact
Lack of detailed histopathological confirmation can lead to audit issues.
Mitigation Strategy
Ensure all pathology reports are complete and included in patient records.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Parathyroid Adenoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Parathyroid Adenoma
Use these documentation templates to ensure complete and accurate documentation for Parathyroid Adenoma. These templates include all required elements for proper coding and billing.
Postoperative Documentation
Specialty: EndocrinologyRequired Elements
- Intraoperative PTH levels
- Histopathological findings
- Surgical procedure details
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Parathyroid Adenoma? Ask your questions below.